US Stock MarketDetailed Quotes

CYTH Cyclo Therapeutics

Watchlist
  • 0.598
  • +0.028+4.91%
Close Dec 27 16:00 ET
  • 0.575
  • -0.023-3.83%
Post 20:01 ET
19.58MMarket Cap-0.66P/E (TTM)

Cyclo Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-102.72%-8.19M
-10.62%-3.85M
-41.46%-6.18M
-7.08%-16.19M
-56.36%-4.29M
-27.02%-4.04M
20.14%-3.48M
9.52%-4.37M
-0.73%-15.11M
-5.17%-2.75M
Net income from continuing operations
-85.12%-8.83M
-29.00%-5.98M
13.26%-4.34M
-29.81%-20.06M
-13.29%-5.64M
-12.35%-4.77M
-34.31%-4.64M
-80.66%-5.01M
-8.15%-15.45M
-78.36%-4.98M
Operating gains losses
--0
--0
--11.81K
----
----
----
----
----
---158.52K
--0
Depreciation and amortization
-54.82%2.18K
-54.82%2.18K
-54.82%2.18K
-1.05%19.28K
-1.05%4.82K
-6.04%4.82K
1.65%4.82K
1.65%4.82K
15.77%19.48K
15.76%4.87K
Other non cash items
----
----
--92.13K
----
----
----
----
----
----
----
Change In working capital
-309.87%-1.1M
18.47%1.15M
-492.04%-2.12M
6,461.58%3.06M
-50.72%1.03M
-45.65%523.3K
191.92%967.49K
126.33%540.36K
96.08%-48.15K
479.41%2.09M
-Change in receivables
51.74%-103.95K
-128.98%-12.42K
166.97%51.06K
-115.75%-67.39K
-41.02%181.38K
-680.24%-215.37K
114.69%42.83K
-120.34%-76.23K
196.36%427.85K
292.01%307.55K
-Change in inventory
-81.71%4.92K
-80.88%1.5K
18.29%11.82K
-95.10%-52.78K
-685.84%-97.52K
355.49%26.89K
119.85%7.85K
56.62%9.99K
-358.35%-27.05K
-36.85%16.65K
-Change in prepaid assets
-581.24%-891.33K
129.75%201.93K
-54.37%-612.69K
74.12%-64.32K
-28.79%826.21K
16.89%185.21K
-1,497.92%-678.85K
75.44%-396.91K
79.33%-248.56K
825.37%1.16M
-Change in payables and accrued expense
-120.49%-107.86K
-40.13%955.2K
-256.56%-1.57M
1,719.66%3.25M
-80.03%121.79K
-32.15%526.41K
307.31%1.6M
222.73%1M
-149.09%-200.39K
-6.96%609.81K
-Change in other working capital
----
----
----
--2.04K
--154
--155
144.93%155
202.34%1.57K
----
----
Cash from discontinued investing activities
Operating cash flow
-102.72%-8.19M
-10.62%-3.85M
-41.46%-6.18M
-7.08%-16.19M
-56.36%-4.29M
-27.02%-4.04M
20.14%-3.48M
9.52%-4.37M
-0.73%-15.11M
-5.17%-2.75M
Investing cash flow
Cash flow from continuing investing activities
-106.34%-2.42K
157.52%38.17K
0
Net PPE purchase and sale
----
----
----
83.96%-2.42K
----
----
----
----
32.95%-15.09K
--0
Net other investing changes
----
----
----
----
----
----
----
----
42.69%53.26K
--0
Cash from discontinued investing activities
Investing cash flow
----
----
----
-106.34%-2.42K
----
----
----
----
157.52%38.17K
--0
Financing cash flow
Cash flow from continuing financing activities
59.92%8M
-42.00%1.97M
-101.85%-69.28K
352,373.00%23.89M
11.74M
5M
3.41M
55,107.98%3.74M
-99.96%6.78K
0
Net issuance payments of debt
--8M
----
----
--0
--0
--0
----
----
200.00%6.78K
--0
Net common stock issuance
--0
--0
--0
--9.74M
--509.73K
--5M
--2.9M
--1.33M
--0
--0
Proceeds from stock option exercised by employees
--0
--0
--0
--4.8M
--1.88M
--1.48K
--509.79K
--2.41M
--0
--0
Net other financing activities
---1.4K
---25.23K
---69.28K
--9.35M
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
59.92%8M
-42.00%1.97M
-101.85%-69.28K
352,373.00%23.89M
--11.74M
--5M
--3.41M
55,107.98%3.74M
-99.96%6.78K
--0
Net cash flow
Beginning cash position
33.31%1.12M
227.28%3M
499.10%9.25M
-90.71%1.54M
-58.00%1.8M
-88.71%841.53K
-92.24%915.18K
-90.71%1.54M
29.32%16.61M
-49.18%4.29M
Current changes in cash
-120.18%-193.8K
-2,443.74%-1.87M
-895.06%-6.25M
151.12%7.7M
371.04%7.44M
130.36%960.28K
98.31%-73.65K
86.95%-628.24K
-500.08%-15.07M
-133.61%-2.75M
End cash Position
-48.50%928.01K
33.31%1.12M
227.28%3M
499.10%9.25M
499.10%9.25M
-58.00%1.8M
-88.71%841.53K
-92.24%915.18K
-90.71%1.54M
-90.71%1.54M
Free cash flow
-102.72%-8.19M
-10.62%-3.85M
-41.46%-6.18M
-6.99%-16.19M
-56.45%-4.3M
-26.61%-4.04M
20.14%-3.48M
9.61%-4.37M
-0.68%-15.13M
-5.17%-2.75M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -102.72%-8.19M-10.62%-3.85M-41.46%-6.18M-7.08%-16.19M-56.36%-4.29M-27.02%-4.04M20.14%-3.48M9.52%-4.37M-0.73%-15.11M-5.17%-2.75M
Net income from continuing operations -85.12%-8.83M-29.00%-5.98M13.26%-4.34M-29.81%-20.06M-13.29%-5.64M-12.35%-4.77M-34.31%-4.64M-80.66%-5.01M-8.15%-15.45M-78.36%-4.98M
Operating gains losses --0--0--11.81K-----------------------158.52K--0
Depreciation and amortization -54.82%2.18K-54.82%2.18K-54.82%2.18K-1.05%19.28K-1.05%4.82K-6.04%4.82K1.65%4.82K1.65%4.82K15.77%19.48K15.76%4.87K
Other non cash items ----------92.13K----------------------------
Change In working capital -309.87%-1.1M18.47%1.15M-492.04%-2.12M6,461.58%3.06M-50.72%1.03M-45.65%523.3K191.92%967.49K126.33%540.36K96.08%-48.15K479.41%2.09M
-Change in receivables 51.74%-103.95K-128.98%-12.42K166.97%51.06K-115.75%-67.39K-41.02%181.38K-680.24%-215.37K114.69%42.83K-120.34%-76.23K196.36%427.85K292.01%307.55K
-Change in inventory -81.71%4.92K-80.88%1.5K18.29%11.82K-95.10%-52.78K-685.84%-97.52K355.49%26.89K119.85%7.85K56.62%9.99K-358.35%-27.05K-36.85%16.65K
-Change in prepaid assets -581.24%-891.33K129.75%201.93K-54.37%-612.69K74.12%-64.32K-28.79%826.21K16.89%185.21K-1,497.92%-678.85K75.44%-396.91K79.33%-248.56K825.37%1.16M
-Change in payables and accrued expense -120.49%-107.86K-40.13%955.2K-256.56%-1.57M1,719.66%3.25M-80.03%121.79K-32.15%526.41K307.31%1.6M222.73%1M-149.09%-200.39K-6.96%609.81K
-Change in other working capital --------------2.04K--154--155144.93%155202.34%1.57K--------
Cash from discontinued investing activities
Operating cash flow -102.72%-8.19M-10.62%-3.85M-41.46%-6.18M-7.08%-16.19M-56.36%-4.29M-27.02%-4.04M20.14%-3.48M9.52%-4.37M-0.73%-15.11M-5.17%-2.75M
Investing cash flow
Cash flow from continuing investing activities -106.34%-2.42K157.52%38.17K0
Net PPE purchase and sale ------------83.96%-2.42K----------------32.95%-15.09K--0
Net other investing changes --------------------------------42.69%53.26K--0
Cash from discontinued investing activities
Investing cash flow -------------106.34%-2.42K----------------157.52%38.17K--0
Financing cash flow
Cash flow from continuing financing activities 59.92%8M-42.00%1.97M-101.85%-69.28K352,373.00%23.89M11.74M5M3.41M55,107.98%3.74M-99.96%6.78K0
Net issuance payments of debt --8M----------0--0--0--------200.00%6.78K--0
Net common stock issuance --0--0--0--9.74M--509.73K--5M--2.9M--1.33M--0--0
Proceeds from stock option exercised by employees --0--0--0--4.8M--1.88M--1.48K--509.79K--2.41M--0--0
Net other financing activities ---1.4K---25.23K---69.28K--9.35M------------------------
Cash from discontinued financing activities
Financing cash flow 59.92%8M-42.00%1.97M-101.85%-69.28K352,373.00%23.89M--11.74M--5M--3.41M55,107.98%3.74M-99.96%6.78K--0
Net cash flow
Beginning cash position 33.31%1.12M227.28%3M499.10%9.25M-90.71%1.54M-58.00%1.8M-88.71%841.53K-92.24%915.18K-90.71%1.54M29.32%16.61M-49.18%4.29M
Current changes in cash -120.18%-193.8K-2,443.74%-1.87M-895.06%-6.25M151.12%7.7M371.04%7.44M130.36%960.28K98.31%-73.65K86.95%-628.24K-500.08%-15.07M-133.61%-2.75M
End cash Position -48.50%928.01K33.31%1.12M227.28%3M499.10%9.25M499.10%9.25M-58.00%1.8M-88.71%841.53K-92.24%915.18K-90.71%1.54M-90.71%1.54M
Free cash flow -102.72%-8.19M-10.62%-3.85M-41.46%-6.18M-6.99%-16.19M-56.45%-4.3M-26.61%-4.04M20.14%-3.48M9.61%-4.37M-0.68%-15.13M-5.17%-2.75M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.